Transurethral en bloc resection of nonmuscle invasive bladder cancer: Trend or hype

Current Opinion in Urology

Volumn 27, Issue 2, 2017, Pages 182-190

  Herrmann, Thomas R W ^a,b   Wolters, Mathias ^a   Kramer, Mario W ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Bladder cancer; Bladder carcinoma; En bloc resection of bladder tumor; Laser; Transurethral resection bladder tumor

Indexed keywords

CANCER RECURRENCE; CANCER STAGING; DISEASE MARKER; ENERGY RESOURCE; FOLLOW UP; HUMAN; INFORMATION; LASER; MORBIDITY; NON MUSCLE INVASIVE BLADDER CANCER; PRIORITY JOURNAL; REVIEW; TRANSURETHRAL EN BLOC RESECTION; TRANSURETHRAL RESECTION; TUMOR LOCALIZATION; TUMOR VOLUME; BLADDER TUMOR; CARCINOMA; CYSTECTOMY; PATHOLOGY; PROCEDURES; TUMOR RECURRENCE; UROLOGIC SURGERY; UROTHELIUM;

CARCINOMA; CYSTECTOMY; HUMANS; NEOPLASM RECURRENCE, LOCAL; URINARY BLADDER NEOPLASMS; UROLOGIC SURGICAL PROCEDURES; UROTHELIUM;

EID: 85007420508     PISSN: 09630643     EISSN: 14736586     Source Type: Journal    
DOI: 10.1097/MOU.0000000000000377     Document Type: Review

References (54)

1. Ploeg M, Aben KK, Kiemeney LA. The present and future burden of urinary bladder cancer in the world. World J Urol 2009; 27:289-293.
2. Leal J, Luengo-Fernandez R, Sullivan R, Witjes JA. Economic burden of bladder cancer across the European Union. Eur Urol 2016; 69:438-447.
3. Burger M, Catto JW, Dalbagni G, et al. Epidemiology and risk factors of urothelial bladder cancer. Eur Urol 2013; 63:234-241.
4. Alfred Witjes J, Lebret T, Compérat EM, et al. Updated 2016 EAU Guidelines on muscle-invasive and metastatic bladder cancer. Eur Urol 2016. doi:10.1016/j.eururo.2016.06.020.
5. Babjuk M, Bohle A, Burger M, et al. EAU Guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur Urol 2016. doi:10.1016/j.eururo.2016.05.041.
6. Ray ER, O'Brien TS. Should urologists be spending more time on the golf course? BJU Int 2007; 100:728-729.
7. Wilby D, Thomas K, Ray E, et al. Bladder cancer: new TUR techniques. World J Urol 2009; 27:309-312.
8. Onishi T, Sugino Y, Shibahara T, et al. Randomized controlled study of the efficacy and safety of continuous saline bladder irrigation after transurethral resection for the treatment of non-muscle-invasive bladder cancer. BJU Int 2016. doi:10.1111/bju.13599.
9. Herr HW, Donat SM. Quality control in transurethral resection of bladder tumours. BJU Int 2008; 102:1242-1246.
10. Sfakianos JP, Kim PH, Hakimi AA, Herr HW. The effect of restaging transurethral resection on recurrence and progression rates in patients with non-muscle invasive bladder cancer treated with intravesical bacillus Calmette-Guérin. J Urol 2014; 191:341-345.
11. Brausi M, Collette L, Kurth K, et al., EORTC Genito-Urinary Tract Cancer Collaborative Group. Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage TaT1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies. Eur Urol 2002; 41:523-531.
12. Grimm M-O, Steinhoff C, Simon X, et al. Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study. J Urol 2003; 170:433-437.
13. Divrik RT, Yildirim U, Zorlu F, Ozen H. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial. J Urol 2006; 175:1641-1644.
14. Lazica DA, Roth S, Brandt AS, et al. Second transurethral resection after ta high-grade bladder tumor: a 4.5-year period at a single university center. Urol Int 2014; 92:131-135.
15. Vasdev N, Dominguez-Escrig J, Paez E, et al. The impact of early re-resection in patients with pT1 high-grade non-muscle invasive bladder cancer. Ecancermedicalscience 2012; 6:3-10.
16. Steinmaus C, Ferreccio C, Acevedo J, et al. High risks of lung disease associated with early-life and moderate lifetime arsenic exposure in northern Chile. Toxicol Appl Pharmacol 2016; 313:10-15.
17. Mariappan P, Zachou A, Grigor KM. Detrusor muscle in the first, apparently complete transurethral resection of bladder tumour Specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience. Eur Urol 2010; 57:843-849.
18. O'Brien T, Ray E, Chatterton K, et al. Prospective randomized trial of hexylaminolevulinate photodynamic-assisted transurethral resection of blad-dertumour (TURBT) plus single-shot intravesical mitomycin Cvs conventional white-light TURBT plus mitomycin C in newly presenting non-muscle-invasive bladder cancer. BJU Int 2013; 112:1096-1104.
19. Gontero P, Sylvester R, Pisano F, et al. The impact of re-transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high-grade/Grade 3 bladder cancer treated with bacille Calmette-Guérin. BJU Int 2016; 118:44-52.
20. He D, Fan J, Wu K, et al. Novel green-light KTP laser en bloc enucleation for nonmuscle-invasive bladder cancer: technique and initial clinical experience. J Endourol 2014; 28:975-979.
21. Hurle R, Lazzeri M, Colombo P, et al. En bloc resection of nonmuscle invasive bladder cancer: a prospective single-center study. Urology 2015; 90: 126-130.
22. Muto G, Collura D, Giacobbe A, et al. Thulium:yttrium-aluminum-garnet laser for en bloc resection of bladder cancer: clinical and histopathologic advantages. Urology 2014; 83:851-855.
23. Migliari R, Buffardi A, Ghabin H. Thulium laser endoscopic en bloc enucleation. 2015; 29:1258-1262.
24. Kramer MW, Rassweiler JJ, Klein J, et al. En bloc resection of urothelium carcinoma of the bladder (EBRUC): a European multicenter study to compare safety, efficacy, and outcome of laser and electrical en bloc transurethral resection of bladder tumor. World J Urol 2015; 33:1937-1943.
25. Kramer MW, Abdelkawi IF, Wolters M, et al. Current evidence for transurethral en bloc resection of nonmuscle-invasive bladder cancer. Minim invasive Ther allied Technol 2014; 23:206-213.
26. Kramer MW, Wolters M, Cash H, et al. Current evidence of transurethral Ho:YAG and Tm:YAG treatment of bladder cancer: update 2014. World J Urol 2015; 33:571-579.
27. Kramer MW, Bach T, Wolters M, et al. Current evidence for transurethral laser therapy of non-muscle invasive bladder cancer. World J Urol 2011; 29: 433-442.
28. Hansel DE, Amin MB, Comperat E, et al. A contemporary update on pathology standards for bladder cancer: transurethral resection and radical cystectomy specimens. Eur Urol 2013; 63:321-332.
29. Liu H, Wu J, Xue S, et al. Comparison of the safety and efficacy of conventional monopolar and 2-micron laser transurethral resection in the management of multiple nonmuscle-invasive bladder cancer. J Int Med Res 2013; 41:984-992.
30. Chen X, Liao J, Chen L, et al. En bloc transurethral resection with 2-micron continuous-wave laser for primary non-muscle-invasive bladder cancer: a randomized controlled trial. World J Urol 2014; 33:989-995.
31. Chen J, Zhao Y, Wang S, et al. Green-light laser en bloc resection for primary non-muscle-invasive bladder tumor versus transurethral electroresection: a prospective, nonrandomized two-center trial with 36-month follow-up. Lasers Surg Med 2016; 48:859-865.
32. Kawada T, Ebihara K, Suzuki T, et al. A new technique for transurethral resection of bladder tumors: rotational tumor resection using a new arched electrode. J Urol 1997; 157:2225-2226.
33. Das A, Gilling P, Fraundorfer M. Holmium laser resection of bladder tumors (HoLRBT). Tech Urol 1998; 4:12-14.
34. Karl A, Herrmann TR. En bloc resection of urothelial cancer within the urinary bladder: the upcoming gold standard? World J Urol 2015; 33:581-582.
35. Kramer MW, Wolters M, Herrmann TR. En bloc resection of bladder tumors: ready for prime time? Eur Urol 2016; 69:4-5.
36. Nagele U, Kugler M, Nicklas A, et al. Waterjet hydrodissection: first experiences and short-term outcomes of a novel approach to bladder tumor resection. World J Urol 2011; 29:423-427.
37. Fritsche HM, Otto W, Eder F, et al. Water-jet-aided transurethral dissection of urothelial carcinoma: a prospective clinical study. J Endourol 2011; 25:1599-1603.
38. Xishuang S, Deyong Y, Xiangyu C, et al. Comparing the safety and efficiency of conventional monopolar, plasmakinetic, and holmium laser transurethral resection of primary nonmuscle invasive bladder cancer. J Endourol 2010; 24:69-73.
39. Wolters M, Kramer MW, Becker JU, et al. Tm:YAG laser en bloc mucosectomy for accurate staging of primary bladder cancer: early experience. World J Urol 2011; 29:429-432.
40. Bach T, Huck N, Wezel F, et al. 70 vs 120 W thulium: Yttrium-aluminiumgarnet 2 microm continuous-wave laser for the treatment of benign prostatic hyperplasia: a systematic ex-vivo evaluation. BJU Int 2010; 106:368-371.
41. Teichmann HO, Herrmann TR, Bach T. Technical aspects of lasers in urology. World J Urol 2007; 25:221-225.
42. Geavlete B, Multescu R, Georgescu D, et al. Narrow band imaging cystoscopy and bipolar plasma vaporization for large nonmuscle-invasive bladder tumors: results of a prospective, randomized comparison to the standard approach. Urology 2012; 79:846-851.
43. Comploj E, Dechet CB, Mian M, et al. Perforation during TUR of bladder tumours influences the natural history of superficial bladder cancer. World J Urol 2014; 32:1219-1223.
44. Venkatramani V, Panda A, Manojkumar R, Kekre NS. Monopolar versus bipolar transurethral resection of bladder tumors: a single center, parallel arm, randomized, controlled trial. J Urol 2014; 191:1703-1707.
45. Sugihara T, Yasunaga H, Horiguchi H, et al. Comparison of perioperative outcomes including severe bladder injury between monopolar and bipolar transurethral resection of bladder tumors: a population based comparison. J Urol 2014; 192:1355-1359.
46. Sureka SK, Agarwal V, Agnihotri S, et al. Is en-bloc transurethral resection of bladder tumor for non-muscle invasive bladder carcinoma better than conventional technique in terms of recurrence and progression?: a prospective study. Indian J Urol 2014; 30:144-149.
47. Herrmann TR. Long-term outcome after endoscopic enucleation of the prostate: From monopolar enucleation to HoLEP and from HoLEP to EEP. Urologe A 2016; 55:1446-1454.
48. Herrmann TR. Enucleation is enucleation is enucleation is enucleation. World J Urol 2016; 34:1353-1355.
49. Bach T, Muschter R, Herrmann TR, et al. Technical solutions to improve the management of non-muscle-invasive transitional cell carcinoma: summary of a European Association of Urology Section for Uro-Technology (ESUT) and Section for Uro-Oncology (ESOU) expert meeting and current and future pers. BJU Int 2015; 115:14-23.
50. Ukai R, Hashimoto K, Iwasa T, Nakayama H. Transurethral resection in one piece (TURBO) is an accurate tool for pathological staging of bladder tumor. Int J Urol 2010; 17:708-714.
51. Zhu Y, Jiang X, Zhang J, et al. Safety and efficacy of holmium laser resection for primary nonmuscle-invasive bladder cancer versus transurethral electroresection: single-center experience. Urology 2008; 72:608-612.
52. De Nunzio C, Franco G, Cindolo L, et al. Transuretral resection of the bladder (TURB): analysis of complications using a modified Clavien system in an Italian real life cohort. Eur J Surg Oncol 2014; 40:90-95.
53. Gao X, Ren S, Xu C, Sun Y. Thulium laser resection via a flexible cystoscope for recurrent non-muscle-invasive bladder cancer: initial clinical experience. BJU Int 2008; 102:1115-1118.
54. Teng JF, Wang K, Yin L, et al. Holmium laser versus conventional transurethral resection of the bladder tumor. Chin Med J (Engl) 2013; 126:1761-1765.